Qiagen N.V.

NYSE:QGEN

Medical - Diagnostics & Research

Healthcare
$49.56 -0.96%

-$0.35 today

Market cap
$10.23B
Beta
0.66
P/E (TTM)
18.6
EPS (TTM)
$1.94
Dividend yield
0.69%
52W Low $32.53High $57.82

Volume 4.26M

Average 2.07M

QGEN Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Qiagen N.V.NYSE: QGEN

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 63.6%

Gross margin was 63.6% in Q2 FY2026, up 1.0 pp from a year earlier. On a trailing-twelve-month basis it was 61.8%, down 1.1 pp year over year. Over 3 fiscal years it narrowed by 2.9 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
63.6%+0.7 pp QoQ
Last fiscal yearDec 2025
61.8%+12.9 pp YoY
LTMJun 2026
61.8%-1.1 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.0 pp——
1 year+12.9 pp——
3 years-2.9 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
61.8%
Year-over-year change
+12.9pp

Gross Margin vs competitors

How QGEN compares with its peers on the latest reported figures

  • QGEN's LTM Jun 2026 gross margin of 61.8% is the 3rd highest of the 11 companies compared; the peer median is 52.0%.
  • Its year-over-year change of -1.1 pp is the 8th highest of 11, against a peer median of +0.6 pp.
  • Over three fiscal years its change of -2.9 pp compares with a peer median of -2.9 pp.
QGEN Competitors Peer median
Gross Margin for QGEN and competitors
Company Period LTM level YoY 3-year change
TXG10x Genomics, Inc.LTM Sep 202671.9% +3.0 pp-7.6 pp
TECHBio-Techne CorporationLTM Sep 202665.8% +0.4 pp-2.0 pp
QGENQiagen N.V.LTM Jun 202661.8% -1.1 pp-2.9 pp
DHRDanaher CorporationLTM Sep 202658.6% -2.7 pp+0.2 pp
AAgilent Technologies, Inc.LTM Jul 202653.7% +0.8 pp-1.9 pp
RVTYRevvity, Inc.LTM Jul 202652.1% -1.9 pp-0.1 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 202651.9% -0.9 pp-3.9 pp
RGENRepligen CorporationLTM Jun 202651.1% +6.8 pp-9.8 pp
BRKRBruker CorporationLTM Jun 202646.7% -1.6 pp-5.7 pp
TMOThermo Fisher Scientific Inc.LTM Sep 202641.4% +1.0 pp-1.4 pp
MRVIMaravai LifeSciences Holdings, Inc.LTM Jun 202634.6% +5.5 pp-62.9 pp
Peer median (excluding QGEN) 52.0%+0.6 pp-2.9 pp

Competitors are the stored peer set for QGEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.25B2.14B1.97B1.98B2.09B
Cost of Revenue800.84M756.96M731.62M1.01B798.5M
Gross Profit1.45B1.38B1.23B967.35M1.29B
Gross Margin64.4%64.7%62.8%48.9%61.8%
Research & Development189.96M189.86M198.51M193.49M187.52M
Selling, General & Admin584.47M603.95M579.17M564.36M583.67M
Operating Expenses820.74M853.1M823.75M869.64M771.19M
Depreciation & Amortization214.93M208.4M205.34M203.27M193.75M
EBITDA895.24M779.36M688.56M368.26M717.27M
EBITDA Margin39.8%36.4%35.0%18.6%34.3%
Operating Income630.08M531.46M409.94M97.71M520.31M
Operating Margin28.0%24.8%20.9%4.9%24.9%
Interest Income9.56M32.76M78.99M68.02M64.32M
Interest Expense54.48M58.36M53.41M43.84M33.26M
Other Income / Expenses(4.25M)(18.86M)19.87M23.44M(30.04M)
Income Before Tax625.83M512.6M429.81M121.15M490.27M
Pre-Tax Margin27.8%23.9%21.9%6.1%23.5%
Income Tax Expense113.23M89.39M88.51M37.56M65.39M
Net Income512.6M423.21M341.3M83.59M424.88M
Net Margin22.8%19.8%17.4%4.2%20.3%
EPS (Basic)2.522.081.670.392.04
EPS (Diluted)2.472.051.650.382.04
Weighted Avg Shares221.14M220.75M217.49M216.44M207.94M
Weighted Avg Shares (Diluted)225.07M223.23M217.49M218.48M207.94M

Qiagen N.V.

NYSE:QGEN

Intrinsic Alpha fair value

Locked

Current Price

$49.56

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.